Methotrexate 2.5mg Tablets
1. What Methotrexate tablets are and what they are used for_
S0452-1OO-PL-PIL-15.08.2014 PACKAGE LEAFLET: INFORMATION FOR THE USER
Methotrexate 2.5mg tablets
Your medicine is available using the above name, but will be referred to as Methotrexate tablets throughout the remainder of this leaflet.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.
What is in this leaflet:
1. What Methotrexate tablets are and what they are used for
2. What you need to know before you take Methotrexate tablets
3. How to take Methotrexate tablets
4. Possible side effects
5. How to store Methotrexate tablets
6. Contents of the pack and other information
The active substance of Methotrexate tablets, methotrexate, is an antimetabolite and immunosuppressant (medicine which affects the reproduction of the body’s cells and reduces the activity of the immune system).
Methotrexate tablets are used to treat:
• active rheumatoid arthritis,
• severe psoriasis, especially plaque-type,
• psoriatic arthritis in adult patients who have tried other treatments but their illness has not improved.
Your doctor will be able to explain how Methotrexate tablets might help in your particular condition.
2. What you need to know before you take Methotrexate tablets
Do not take Methotrexate tablets:
• if you have significant liver disease (your doctor decides the severity of your disease).
• if you have significant kidney disease (your doctor decides the severity of your disease).
• if you have or have had a bone marrow disease or serious blood disorders.
• if you are allergic (hypersensitive) to methotrexate or any of the other ingredients of Methotrexate tablets.
• if you are pregnant or breast-feeding
(see also section “Pregnancy, breast-feeding and fertility”).
• if you have severe acute or chronic infections or immunodeficiency syndrome.
• if you suffer from alcoholism.
Warnings and precautions
Please tell your doctor or pharmacist if any of the following conditions concern or have concerned you:
• Diabetes mellitus treated with insulin.
• You have received any vaccinations recently or are you due to have any
• You are using any other medicines or vitamin products (Please see section “Other medicines and Methotrexate tablets”)
• You have infections
• You have ulcerations in your stomach or bowel (peptic ulcer or ulcerative colitis)
• You are in poor general condition
• You have or have had any liver or kidney disease.
Methotrexate tablets temporarily affect sperm and egg production. You and your partner should avoid conception (becoming pregnant or fathering children) if currently receiving methotrexate and for at least six months after your treatment with methotrexate has stopped. See also section “Pregnancy, breast-feeding and fertility”.
Before treatment is started your doctor may carry out blood tests, and also to check how well your kidneys and liver are working. You may also have a chest X-ray. Further tests may also be done during and after treatment. Do not miss appointments for blood tests.
Other medicines and Methotrexate tablets
Other concomitant medication may affect the efficacy and safety of this medicine.
Methotrexate tablets may also affect the efficacy and safety of other medications.
Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription and herbal or natural medicinal products. Remember to tell your doctor about your treatment with Methotrexate tablets, if you are prescribed another medicine while the treatment is still ongoing. It is especially important to tell your doctor if you are using:
• certain antibiotics (such as penicillins, sulphonamides, trimethoprim/sulfamethoxazole, tetracycline and chloramphenicol);
• agents that may be harmful to kidneys and liver [e.g. sulphasalazine and leflunomide (medicines for rheumatic diseases), vitamin A and its derivatives, alcohol];
• anticancer agents (e.g. cisplatin, mercaptopurine);
• phenytoin (medicine often used to treat epilepsy);
• aspirin or similar medicines (known as salicylates);
• non-steroidal anti-inflammatory medicines (medicines taken for pain relief) e.g. ibuprofen and pyrazoles;
• medicines taken to help control rheumatism e.g. azathioprine;
• omeprazole or pantoprazole (medicine used to stop the production of stomach acid);
• diuretics, triamterene (water tablets);
• probenecid (medicine used to treat gout);
• folic acid (vitamin preparation):
• theophylline (medicine used to treat respiratory diseases);
• cyclosporine (an agent that can suppress or prevent the immune response).
Tell your physician about use of Methotrexate tablets during your next visits.
Methotrexate tablets with food, drink and alcohol
Alcohol should be avoided during methotrexate therapy.
Pregnancy, breast-feeding and fertility
Pregnancy
Do not use Methotrexate tablets during pregnancy or if you are trying to become pregnant. Methotrexate tablets can cause birth defects, harm unborn babies or cause miscarriages and so it is very important that it is not given to pregnant patients or patients planning to become pregnant.
Therefore, in women of child-bearing age any possibility of pregnancy must be excluded with appropriate measures, e.g. a pregnancy test, before starting treatment. You must avoid becoming pregnant whilst taking methotrexate and for at least 6 months after treatment is stopped. Therefore you must ensure reliable contraception during this whole period (see also section “Take special care with Methotrexate tablets”).
If you do become pregnant during treatment, you should be offered advice regarding the risk of harmful effects on the child through treatment.
If you wish to become pregnant you should consult a genetic information centre before the planned start of treatment, because methotrexate may be genotoxic, which means that the medicine may cause genetic mutation.
Breast-feeding
Do not breastfeed during treatment, because methotrexate passes into breast milk. If your attending doctor considers treatment with methotrexate absolutely necessary during the lactation period, you must stop breast-feeding.
Fertility Male fertility
Methotrexate tablets may be genotoxic. This means that the medicine may cause genetic mutation. Methotrexate tablets can affect sperm and egg production with the potential to cause birth defects. Therefore, you must avoid fathering a child whilst taking methotrexate and for at least 6 months after treatment is stopped. Since treatment with methotrexate may lead to infertility, it might be advisable for male patients to look into the possibility of sperm preservation before starting treatment (see also section “Take special care with Methotrexate tablets”).
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
You can feel fatigue and dizziness during Methotrexate tablets treatment. Do not drive or use machines if you have such symptoms.
Methotrexate tablets contains lactose
These tablets contain lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
How to take Methotrexate tablets
Always take Methotrexate tablets exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
• Take Methotrexate tablets once a week
• Patients with rheumatoid arthritis or psoriasis will usually take their tablets orally once a week on the same day each week.
• Do not take tablets more often than your doctor has told you to.
• Daily administration can lead to serious toxic effects.
• Take the tablets with a glass of water whilst sitting upright or standing.
Dosage for rheumatoid arthritis, psoriasis and psoriatic arthritis:
The recommended dose is 7.5-15 mg orally, once weekly.
This should be adjusted according to your response to treatment and side effects.
If you take more Methotrexate tablets than you should
If you take (or someone else has taken) more of the medicine than you should, a physician or nearest hospital casualty department must be contacted immediately.
An overdose of methotrexate can lead to severe toxic reactions. Overdose symptoms may include easy bruising or bleeding, unusual weakness, mouth sores, nausea, vomiting, black or bloody stools, coughing up blood or vomit that looks like coffee grounds, and decreased urinating. See also section 4.
Take your medicine package with you if you go to a doctor or hospital.
If you forget to take Methotrexate tablets
Take the forgotten dose as soon as you remember if this is within two days.
However, if you have missed a dose by more than two days, please contact your doctor for advice. Do not take a double dose to make up a forgotten dose.
Make sure before your holiday or trip that you have enough of your medicine.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. In general, the incidence and severity of adverse reactions of methotrexate are related to dose and frequency of administration. Most adverse reactions are reversible if detected early.
Most of the effects listed below will only be seen in patients who are receiving high doses of methotrexate to treat cancer. They are not seen as often and are not as severe at the doses used in the treatment of psoriasis or rheumatoid arthritis.
Common side effects (occurs in more than 1 of 100 patients and less than 1 of 10 patients): Decreased resistance to infections, leucosytopenia (decreased number of white blood cells)*, nausea, vomiting, diarrhoea, unusual fatigue, headache, dizziness, loss of appetite, erythematous rashes, alopecia, stomatitis (soreness of the mouth and lips) and increase of liver transaminases (enzymes)*.
Uncommon side effects (occurs in more than 1 of 1000 patients and less than 1 of 100 patients): Bone marrow depression manifested by thrombocytopenia and other abnormalities developing in the blood*, anaemia, nosebleed, anaphylactic reactions, severe pulmonary illnesses, severe skin rashes, pruritus, kidney dysfunction, vaginal ulceration.
*) Only detected by your doctor.
Rare side-effects (occurs in more than 1 of 10,000 patients and less than 1 of 1000 patient):
Depression, confusion, hemiparesis (impairment of motor function affecting only one side of the body), diabetes mellitus, hypotension, thromboembolia, dyspnoea, inflammation of gums, pharynx or small intestine, gastrointestinal ulceration and bleeding, liver damage (hepatic toxicity, periportal fibrosis, hepatic cirrhosis, acute hepatitis), skin reactions (acne, skin depigmentation, urticaria, photosensitivity, erythema multiforme, burning in skin psoriatic lesions, skin ulcers), appearance of skin nodules, Herpes zoster, sepsis, osteoporosis, pain in joints or muscles, menstrual disorders, impotence, decrease of libido.
If you notice any of the following, please contact your doctor immediately:
• Unusual bleeding (including vomiting blood) or bruising
• severe diarrhoea
• ulcers in mouth
• black or tarry stools
• blood in the urine or stools
• tiny red spots on the skin
• an allergic reaction such as skin rash or swelling of your lips or tongue
• fever
• yellowing of the skin (jaundice)
• pain or difficulty in passing urine
• thirst and/or frequent urination
• chest pain
• a dry cough and/or pain or difficulty in breathing or shortness of breath
• fits (convulsions)
• loss of consciousness
• blurred or decreased vision.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.aov.uk/vellowcard.
By reporting side effects, you can help provide more information on the safety of this medicine.
S0452-100-PL-PIL-15.08.2014
How to store Methotrexate tablets
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the tablet container and the outer carton. The expiry date refers to the last day of that month.
Keep the container in the outer carton, in order to protect from light.
Do not store above 25°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
If your medicine becomes discoloured or shows any signs of deterioration, you should seek the advice of your pharmacist.
6. Contents of the pack and other information
What Methotrexate tablets contain
Each tablet contains 2.5mg methotrexate.
The other ingredients are: lactose monohydrate, maize starch, pregelatinised starch, polysorbate 80, microcrystalline cellulose and magnesium stearate.
What Methotrexate tablets look like and contents of the pack
Yellow, about 6mm in diameter, round, convex, uncoated tablet engraved with ‘M 2.5’ on one side and plain on the other side.
Pack sizes: 100 tablets.
Manufacturer:
Orion Corporation Tengstrominkatu 8 FI-20360 Turku Finland
Procured from within the EU and repackaged by:
Amimed Direct Ltd, Hendon, London, NW9 6AQ. Product Licence Holder: Sam Pharma Ltd, Unit 20 Garrick Industrial Estate, Irving Way, Hendon, London, NW9 6AQ.
POM